Literature DB >> 33527044

Characterization of Progesterone Receptor Expression in Intracranial Meningiomas of Patients Treated in a High-Complexity Hospital in Bogota, Colombia.

Raul Ramirez Grueso1, Linda Barcenas2, Jaime A Arias1, Carlos Colegial2, Claudia L Avendaño3, Jose Chaves1, Jorge Galvis4, Santiago Moreno5.   

Abstract

Background Meningiomas are the single most common brain tumor. The incidence of these tumors increases with age; different studies have shown that meningiomas usually appear after the age of 50. These tumors are more common in women than in men, and women are twice as likely to suffer from the condition. Surgery is the primary form of treatment, which can be curative with complete resection. If the tumor is unresectable or other treatments such as surgery and radiotherapy have failed, hormonal therapy or chemotherapy may be considered. There is limited information about the clinical, demographic, and histopathological characteristics of these tumors in the population of Bogotá, Colombia. Objective To evaluate the expression of progesterone receptors in patients over 18 years old who have been diagnosed with meningiomas in a high-complexity hospital in Bogota, Colombia, and to describe the demographic and histopathological characteristics of these patients. Methods This is a descriptive and retrospective case series. Patients with meningioma who underwent surgical resection at a high-complexity hospital in Bogota, Colombia, from 2016 to 2019 were retrospectively identified and studied. Demographic variables, such as age and gender, were extracted from the clinical chart. Indirect immunoperoxidase staining was carried out for the progesterone receptor (PR) and Ki67. PR is analyzed as positive and negative, and the Ki67 proliferation index was determined. Results Thirty-two meningiomas from patients who underwent surgery were available for analysis. Twenty-five (78.1%) were positive for PR, 71.8% were females, and 93% were World Health Organization (WHO) grade I. Meningothelial (28%), fibrous (25%), and transitional (25%) meningiomas were the most frequent subtypes, correspondingly. The Ki67 mean value was 1.14 (0.11-10.71). Conclusion Our case series showed a greater frequency of meningiomas in women, with a high PR expression and a low Ki67 proliferation rate. These data correlate with literature worldwide.
Copyright © 2020, Ramirez Grueso et al.

Entities:  

Keywords:  ki67; meningioma; progesterone receptor

Year:  2020        PMID: 33527044      PMCID: PMC7842106          DOI: 10.7759/cureus.12355

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  27 in total

1.  "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.

Authors:  A Perry; B W Scheithauer; S L Stafford; C M Lohse; P C Wollan
Journal:  Cancer       Date:  1999-05-01       Impact factor: 6.860

2.  Differentiating meningioma grade by imaging features on magnetic resonance imaging.

Authors:  Andrew T Hale; Li Wang; Megan K Strother; Lola B Chambless
Journal:  J Clin Neurosci       Date:  2017-11-22       Impact factor: 1.961

3.  Predisposing conditions and risk factors for development of symptomatic meningioma in adults.

Authors:  Brigitte Schneider; Heinke Pülhorn; Bernd Röhrig; Nikolai G Rainov
Journal:  Cancer Detect Prev       Date:  2005-09-26

Review 4.  Management of meningioma.

Authors:  Philipp Euskirchen; Matthieu Peyre
Journal:  Presse Med       Date:  2018-11-16       Impact factor: 1.228

5.  WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.

Authors:  Francesco Maiuri; Giuseppe Mariniello; Elia Guadagno; Marcello Barbato; Sergio Corvino; Marialaura Del Basso De Caro
Journal:  Acta Neurochir (Wien)       Date:  2019-10-21       Impact factor: 2.216

6.  Meningioma grading: an analysis of histologic parameters.

Authors:  A Perry; S L Stafford; B W Scheithauer; V J Suman; C M Lohse
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

7.  Progesterone and estrogen receptors in meningiomas: prognostic considerations.

Authors:  D W Hsu; J T Efird; E T Hedley-Whyte
Journal:  J Neurosurg       Date:  1997-01       Impact factor: 5.115

Review 8.  Meningiomas: Overview and New Directions in Therapy.

Authors:  Nancy Wang; Matthias Osswald
Journal:  Semin Neurol       Date:  2018-03-16       Impact factor: 3.420

Review 9.  Epidemiology of intracranial meningioma.

Authors:  W T Longstreth; L K Dennis; V M McGuire; M T Drangsholt; T D Koepsell
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

Review 10.  Intracranial meningiomas: an overview of diagnosis and treatment.

Authors:  Jason Rockhill; Maciej Mrugala; Marc C Chamberlain
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.